Cell · 2015
Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions
Lupiáñez DG, Kraft K, Heinrich V, Krawitz P, Brancati F, Klopocki E, Horn D, Kayserili H, Opitz JM, Laxova R, Santos-Simarro F, Gilbert-Dussardier B, Wittler L, Borschiwer M, Haas SA, Osterwalder M, Franke M, Timmermann B, Hecht J, Spielmann M, Visel A, Mundlos S.
Show affiliations
- Lupiáñez DG — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Kraft K — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Heinrich V — Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Krawitz P — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Brancati F — Medical Genetics Unit, Policlinico Tor Vergata University Hospital, 00133 Rome, Italy.
- Klopocki E — Institute of Human Genetics Biozentrum, Julius Maximilian University of Würzburg, 97070 Würzburg, Germany.
- Horn D — Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Kayserili H — Medical Genetics Department, Istanbul Medical Faculty, Istanbul University, 34093 Istanbul, Turkey.
- Opitz JM — Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT 84108, USA.
- Laxova R — Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT 84108, USA.
- Santos-Simarro F — Instituto de Genética Médica y Molecular (INGEMM), IdiPAZ, Hospital Universitario La Paz, 28046 Madrid, Spain; U753 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28046 Madrid, Spain.
- Gilbert-Dussardier B — Service de Génétique, C.H.U. de Poitiers, 86021 Poitiers, France.
- Wittler L — Department Developmental Genetics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
- Borschiwer M — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany.
- Haas SA — Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
- Osterwalder M — Genomics Division, MS 84-171, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
- Franke M — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Timmermann B — Max Planck Institute for Molecular Genetics, Sequencing Core Facility, 14195 Berlin, Germany.
- Hecht J — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Spielmann M — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Visel A — Genomics Division, MS 84-171, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA; U.S. Department of Energy Joint Genome Institute, Walnut Creek, CA 94598, USA; School of Natural Sciences, University of California, Merced, CA 95343, USA.
- Mundlos S — Max Planck Institute for Molecular Genetics, RG Development & Disease, 14195 Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, 13353 Berlin, Germany. Electronic address: mundlos@molgen.mpg.de.
57 read6 want to readRigor 2.9Novelty 2.8Impact 2.5Reprod. 3.1
Most-cited papers citing this
- Nature · 2025 · cited by 20
- Nat Commun · 2025 · cited by 9
- Cell · 2025 · cited by 8
- Trends Ecol Evol · 2025 · cited by 6
- Nat Genet · 2025 · cited by 5
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0
0
0
0
0
0